Salesforce Inc. $CRM Shares Purchased by Praxis Investment Management Inc.

Praxis Investment Management Inc. boosted its holdings in shares of Salesforce Inc. (NYSE:CRM) by 91.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 25,449 shares of the CRM provider’s stock after buying an additional 12,179 shares during the quarter. Praxis Investment Management Inc.’s holdings in Salesforce were worth $6,742,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Aspire Growth Partners LLC raised its position in shares of Salesforce by 1.2% in the 3rd quarter. Aspire Growth Partners LLC now owns 3,355 shares of the CRM provider’s stock valued at $795,000 after purchasing an additional 39 shares during the last quarter. Byrne Asset Management LLC grew its position in Salesforce by 1.0% during the 4th quarter. Byrne Asset Management LLC now owns 4,331 shares of the CRM provider’s stock worth $1,147,000 after purchasing an additional 43 shares during the last quarter. Mathes Company Inc. grew its position in Salesforce by 0.4% during the 3rd quarter. Mathes Company Inc. now owns 12,558 shares of the CRM provider’s stock worth $2,976,000 after purchasing an additional 45 shares during the last quarter. Fred Alger Management LLC increased its stake in Salesforce by 0.3% during the 3rd quarter. Fred Alger Management LLC now owns 14,943 shares of the CRM provider’s stock valued at $3,548,000 after purchasing an additional 45 shares in the last quarter. Finally, Beacon Capital Management LLC raised its holdings in shares of Salesforce by 3.5% in the third quarter. Beacon Capital Management LLC now owns 1,372 shares of the CRM provider’s stock worth $325,000 after buying an additional 46 shares during the last quarter. 80.43% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Salesforce

In other Salesforce news, Director David Blair Kirk purchased 2,570 shares of the business’s stock in a transaction that occurred on Wednesday, March 18th. The stock was purchased at an average price of $194.62 per share, for a total transaction of $500,173.40. Following the purchase, the director directly owned 13,689 shares in the company, valued at approximately $2,664,153.18. This trade represents a 23.11% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Laura Alber purchased 2,571 shares of the stock in a transaction on Thursday, March 19th. The shares were acquired at an average price of $194.58 per share, for a total transaction of $500,265.18. Following the transaction, the director directly owned 9,530 shares of the company’s stock, valued at $1,854,347.40. This represents a 36.94% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 3.00% of the company’s stock.

Salesforce News Summary

Here are the key news stories impacting Salesforce this week:

• Positive Sentiment: Company reoriented around AI agents and launched Agentforce Operations to automate cross-system back-office work — a strategic shift that underpins Salesforce’s long-term growth story and supports upgraded revenue targets. Salesforce (CRM) Launches Agentforce Operations to Automate Complex Cross-System Back-Office Tasks
• Positive Sentiment: Deeper Google Cloud integration and new AI-focused revenue segments are being highlighted as catalysts that could expand addressable market and support valuation upside as agents get traction. Salesforce (CRM) Valuation Check As AI Agent Push And Google Cloud Integration Gain Traction
• Positive Sentiment: Commercial traction: Merck Animal Health selected Salesforce’s Agentforce Life Sciences for customer engagement, signaling enterprise demand for the new agent-driven offerings. Merck Animal Health Selects Salesforce’s Agentforce Life Sciences for Customer Engagement to Transform Animal Care and Enhance Support Experiences for Employees
• Positive Sentiment: Institutional/analyst support: Barclays named CRM a top pick in infrastructure software and high-profile investors have touted the name; sell-side consensus remains “Buy,” which can provide a floor for sentiment. Is the Market Missing the Point on Salesforce Inc (CRM)’s AI Positioning?
• Neutral Sentiment: Analyst ratings are positive on average, but some commentary warns that consensus recommendations can be overly optimistic — useful context but not an immediate catalyst. Wall Street Analysts See Salesforce (CRM) as a Buy: Should You Invest?
• Neutral Sentiment: Valuation and peer comparisons (e.g., CRM vs. SPOT) are being debated — useful for longer-term allocation decisions but mixed in terms of near-term price impact. CRM vs. SPOT: Which Stock Is the Better Value Option?
• Negative Sentiment: Shares are down despite broader market gains; investors are likely taking profits and reacting to the stock’s weak year-to-date performance and lingering valuation concerns. Salesforce (CRM) Stock Drops Despite Market Gains: Important Facts to Note
• Negative Sentiment: Competition with Microsoft and other large cloud/AI players is intensifying around AI agents — the rivalry increases execution risk and could pressure multiples if market leaders consolidate share. Salesforce and Microsoft escalate AI agent rivalry in CRM

Salesforce Stock Down 3.1%

Shares of CRM stock opened at $181.17 on Thursday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.18. Salesforce Inc. has a twelve month low of $163.52 and a twelve month high of $296.05. The stock has a 50 day moving average of $186.77 and a 200 day moving average of $219.31. The stock has a market cap of $148.23 billion, a P/E ratio of 23.20, a P/E/G ratio of 1.30 and a beta of 1.14.

Salesforce (NYSE:CRM) last issued its quarterly earnings data on Wednesday, February 25th. The CRM provider reported $3.81 EPS for the quarter, topping analysts’ consensus estimates of $3.05 by $0.76. The business had revenue of $11.20 billion for the quarter, compared to analysts’ expectations of $11.18 billion. Salesforce had a net margin of 17.96% and a return on equity of 15.38%. The business’s revenue was up 12.1% on a year-over-year basis. During the same quarter last year, the company earned $2.78 EPS. Salesforce has set its FY 2027 guidance at 13.110-13.190 EPS and its Q1 2027 guidance at 3.110-3.130 EPS. As a group, sell-side analysts expect that Salesforce Inc. will post 9.71 EPS for the current year.

Salesforce announced that its Board of Directors has initiated a stock buyback plan on Monday, March 16th that authorizes the company to repurchase $25.00 billion in outstanding shares. This repurchase authorization authorizes the CRM provider to reacquire up to 14.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Salesforce Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 23rd. Shareholders of record on Thursday, April 9th were given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.0%. This is an increase from Salesforce’s previous quarterly dividend of $0.42. The ex-dividend date was Thursday, April 9th. Salesforce’s payout ratio is currently 22.54%.

Wall Street Analysts Forecast Growth

CRM has been the subject of several research reports. The Goldman Sachs Group reiterated a “buy” rating and set a $281.00 price objective on shares of Salesforce in a research note on Thursday, February 26th. Wedbush restated an “outperform” rating and issued a $375.00 target price on shares of Salesforce in a research note on Tuesday, February 24th. Barclays lowered their price target on Salesforce from $265.00 to $252.00 and set an “overweight” rating for the company in a research report on Thursday, February 26th. Cantor Fitzgerald reissued an “overweight” rating on shares of Salesforce in a report on Thursday, February 26th. Finally, Piper Sandler reduced their price objective on Salesforce from $250.00 to $215.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Salesforce has a consensus rating of “Moderate Buy” and an average price target of $279.18.

Salesforce Profile

Salesforce, founded in 1999 and headquartered in San Francisco, is a global provider of cloud-based software focused on customer relationship management (CRM) and enterprise applications. The company popularized the software-as-a-service (SaaS) model for CRM and has built a broad portfolio of products designed to help organizations manage sales, service, marketing, commerce and analytics through a unified, cloud-first platform.

Core offerings include Sales Cloud for sales automation, Service Cloud for customer support, Marketing Cloud for digital marketing and engagement, and Commerce Cloud for e-commerce.